PTX3 and metabolic dysfunction-associated steatotic liver disease: Our results correspond with those obtained in middle-aged subjects, where plasma PTX-3 levels were significantly higher in stage F3–F4 than F0–F2 NAFLD cases, and plasma PTX-3 concentrations correlated with stages of liver fibrosis regardless of sex (15).